Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans

Diabetes

Volumn 45, Issue 3, 1996, Pages 316-321

  Piatti, PierMarco ^a,b   Monti, Lucilla D ^a   Conti, Morena ^a   Baruffaldi, Laura ^a   Galli, Laura ^a   Phan, Chuong V ^a   Guazzini, Barbara ^a   Pontiroli, Antonio E ^a   Pozza, Guido ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; CORRELATION FUNCTION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULINOMA; MALE; PRIORITY JOURNAL; SYNDROME X; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030059723     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.3.316     Document Type: Article

References (40)

1. Yanagisawa M, Kurihara H, Kumura S, Tomobe Y, Kobayashi M, Mitsui Y, Goto K, Masaki T: A novel potent vasoconstrictor produced by vascular endothelial cells. Nature 332.411-415, 1988
2. Luscher TF, Boulanger CM, Dohi Y, Yang Z: Endothelium derived contracting factors. Hypertension 19:117-130, 1992
3. Haynes W, Webb DJ: Contribution of endogenous generation of endothelin-1 to basal tone. Lancet 344:852-854, 1994
4. Masaki T, Yanagisawa M, Goto K, Kimura S. Role of endothelin in mechanisms of local blood pressure control. J Hypertens 8 (Suppl. 7):S107-S112, 1990
5. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 15:493-496, 1990
6. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T: Plasma immunoreactive endothelin in essential hypertension. Am J Med 88:614-618, 1990
7. Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin-1 in patients with essential hypertension N Engl J Med 322:205, 1990
8. Koyama H, Nishzawa Y, Morii H, Tabata T, Inoue T, Yamajj T: Plasma endothelin levels in patients with uremia. Lancet 1:991-992, 1989
9. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T: Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet ii:53-54, 1989
10. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Takeuchi K, Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 119:801-806, 1990
11. Qiu S, Theroux P, Marcil M, Solymoss BC: Plasma endothelin-1 levels in stable and unstable angina. Cardiology 82:12-19, 1993
12. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325:997-1001, 1991
13. Takahashi K, Ghatli MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus Diabetologia 33. 306-310, 1990
14. Ferri C, Carlomagno A, Coassin S, Baldoncini K, Cassone Faldetta MR, Laurenti O, Properzi G, Santucci A, De Mattia G: Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men. Diabetes Care 18:226-233, 1995
15. Bertello PD, Veglio F, Pinna G, Gurioli L, Molino P, Alban S, Chiandussi L: Plasma endothelin in NIDDM patients with and without complications Diabetes Care 17:574-577, 1994
16. Yoshimoto S, Ishizaki Y, Mori A, Sasaki T, Takakura K, Murota S: The role of cerebral microvessel endothelium in regulation of cerebral blood flow though production of endothelin-1. J Vasc Med Biol 2.178A, 1990
17. Vierhapper H, Wagner O, Nowotny P, Waldhausl W: Effect of endothelin-1 in man. Circulation 81:1415-1418, 1990
18. Emmeluth C, Bie P Effects, release and disposal of endothelin-1 in conscious dogs. Acta Physiol Scand 146:197-204, 1992
19. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797-9800, 1988
20. Shiba R, Yanagisawa M, Miyauchi T, Ishii Y, Kimura S, Uchiyama Y, Masaki T, Goto K: Elimination of intravenously injected endothelin-1 from the circulation of the rat. J Cardiovasc Pharmacol 13 (Suppl. 5):98-101, 1989
21. Aenggard E, Galton S, Rae G: The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 13 (Suppl. 5):46-49, 1989
22. Avogaro P, Crepaldi G, Enzi G, Tiengo A: Association of hyperlipemia, diabetes mellitus and mild obesity. Acta Diabetol Lat 4:572-590, 1967
23. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
24. Haffner SM, Valder RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 41:715-722, 1902
25. De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
26. Carlson LA, Rossner S: A methodological study of an intravenous fat tolerance test with intralipid emulsion. Scand J Clin Lab Invest 29:271-280, 1972
27. Cowett R, Carr SR, Ogburn PL: Lipid tolerance testing in pregnancy. Diabetes Care 16:51-56, 1993
28. Goldeberg IJ, Vanni TM, Ramakrishnan R: Effects of intralipid-induced hypertriglyceridemia on plasma high-density lipoprotein metabolism in the cynomolgus monkey. Metabolism 41:1176-1184, 1992
29. Piatti PM, Monti LD, Pacchioni M, Pontiroli AE, Pozza G: Forearm insulin and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism 40:926-933, 1991
30. Vettor R, Mazzonetto P, Macor C, Scandellari C, Federspil G: Effect of endogenous organic hyperinsulinemia on blood pressure and serum triglycerides. Eur J Clin Invest 24.350-354, 1994
31. Pontiroli AE, Alberetto MG, Pozza G: Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetologia 35:294-295, 1992
32. O'Brien T, Young WF, Palumbo PJ, O'Brien PC, Service FJ: Hypertension and dyslipidemia in patients with insulinoma. Mayo Clin Proc 68:141-146, 1993
33. Wagner OF, Nowotny F, Vierhapper H, Waldhausl W. Plasma concentrations of endothelin in man: arterio-venous differences and release during venous stasis. Eur J Clin invest 20:502-505, 1990
34. Ahlborg G, Weitzberg E, Lundberg JM: Endothelin-1 infusion reduces splanchnic glucose production in humans. J Appl Physiol 77:121-126, 1994
35. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi TM, Wee Soo Shin, Yanagisawa M, Masaki T, Sugimoto T: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83:476-483, 1991
36. Metsarinne K, Saijonmaa O, Yki-Jarvinen H, Fyhrqist F: Insulin increases the release of endothelin in endothelial cell cultures in vitro but not in vivo. Metabolism 43:878-882, 1994
37. Anfossi G, Cavalot F, Massucco P, Mattiello L, Mularoni E, Hann A, Trovati M: Insulin influences immunoreactive endothelin release by vascular smooth muscle cells. Metabolism 42:1081-1083, 1993
38. Olivert FJ, De la Rubia G, Feener EP, Lee M-E, Loeken MR, Shiba T, Quertermous T, King G: Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Cfiem 266:23251-23256, 1991
39. Ito H, Hirata Y, Hiroe M, Tsujjno M, Marumo F: Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209-215, 1991
40. Wolpert HA, Steen SN, Istfan NW, Simonson DC: Insulin modulates circulating endothelin-1 levels in humans. Metabolism 42:1027-1030, 1993